Recursion Pharmaceuticals, Inc. (RXRX)
$4.36+10.38%Close
BUYRECOVERY · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV5.1%–490.7%
- Market cap
- $2.3B
- Beta
- 1.07
- P/E (TTM)
- -4.45
- IV-%ile
- 88
- IV ATM
- 111.7%
- Short % float
- 38.64%
- Days to cover
- 6.1
- SI change
- -11.6%
- 1W
- +5.83%
- 1M
- +37.97%
- vs SPY 1W
- +4.66%
- vs SPY 1M
- +34.98%
Industry peers
FMP comparable companies · ranked by market cap
- IBRXBUYImmunityBio, Inc.$10.9BRECOVERYQ 8$10.38+6.05%
- COGTSELLCogent Biosciences, Inc.$5.3BRECOVERYQ 13$30.87+3.06%
- DNLISELLDenali Therapeutics Inc.$3.2BCRISISQ 8$19.91+4.18%
- RCUSSELLArcus Biosciences, Inc.$3.1BRECOVERYQ 17$24.74+2.43%
- BEAMBUYBeam Therapeutics Inc.$2.6BRECOVERYQ 14$25.67+4.47%
- LQDASELLLiquidia Corporation$2.5BCRISISQ 12$27.64-2.28%
- ETNB89bio, Inc.$2.2B$14.84
- AGIOSELLAgios Pharmaceuticals, Inc.$1.9BRECOVERYQ 4$31.25-0.34%
- SRPTSELLSarepta Therapeutics, Inc.$1.8BRECOVERYQ 13$17.49-1.98%
- GLPGGalapagos N.V.$1.8B$27.98
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on RXRX?
- LOPJLB’s latest quantitative signal on Recursion Pharmaceuticals, Inc. (RXRX) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is RXRX in?
- Recursion Pharmaceuticals, Inc. (RXRX) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Recursion Pharmaceuticals, Inc. (RXRX) do?
- Recursion Pharmaceuticals, Inc. operates as a biotechnology firm currently in its clinical development phase. The company's mission is to revolutionize drug discovery by decoding biological processes, utilizing an integrated approach that combines technological innovations across biology, chemistry, automation, data science, and engineering. Their developmental pipeline features several clinica…